The Vaccine Group
Biotechnology Research • 
Plymouth, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | 14 Research Way, Derriford Research Facility, Plymouth, Devon PL6 8BU, GB |
| Phone number | +441752583298 |
| Websites | |
| NAICS | 541714 |
| Keywords | Molecular Biology, Virology, Vaccine Development, Zoonotic Diseases |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at The Vaccine Group
Jeremy Salt
Chief Executive Officer
The Vaccine Group Email Formats
The Vaccine Group uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@thevaccinegroup.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@thevaccinegroup.com | 66.7% |
{first name}.{last name} | john.doe@thevaccinegroup.com | 33.3% |
About The Vaccine Group
Our missionis to develop herpesvirus-based animal vaccines to protect against infectious diseases. We are using recombinant viral vector technology to develop new vaccines for use in animals to tackle diseases falling into two broad categories: - Zoonotic diseases, such as COVID-19, Ebola and Lassa fever, which jump from animals tohumans; - Diseases such as bovine tuberculosis, porcine reproductive & respiratory syndrome and African Swine Fever which have a high impact on production of economically important livestock. Most emerging infections, especially those with high pandemic potential in humans, emerge from domestic and wildlife animal populations. Due to the earlier ability to test animal vaccines in their intended host, and the relative speed at which animal compared to human vaccines are approved for use, vaccination of animals rather than humans is becoming accepted as an approach to protect humans against some emerging zoonotic pathogens. Our business model is to develop vaccine candidates to Proof of Concept with commercial exploitation delivered through license agreements with vaccine manufacturing companies.
The Vaccine Group revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
The Vaccine Group has 3 employees across 2 departments.
Departments
Number of employees
Funding Data
The Vaccine Group has never raised funding before.
The Vaccine Group Tech Stack
Discover the technologies and tools that power The Vaccine Group's digital infrastructure, from frameworks to analytics platforms.
Security
Hosting
JavaScript libraries
JavaScript libraries
Maps
Page builders
Analytics
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
Analytics
United States
Ghana
Tunisia
Austria
Australia
Frequently asked questions
4.8
40,000 users
